{"questions":[{"id":"open_question-16f7438c-dbaa-410a-a4cd-1c31bb29be20","artifact_type":"open_question","title":"Therapeutic window**: When to intervene for maximum benefit?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.966989+00:00","updated_at":"2026-04-26T03:29:48.966989+00:00"},{"id":"open_question-663be07e-9b88-4ed4-af2f-01c61d103791","artifact_type":"open_question","title":"How do different mutations cause variable phenotypes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:44.553719+00:00","updated_at":"2026-04-26T03:29:44.553719+00:00"},{"id":"open_question-76df1c90-c8af-4d88-9221-c7facd3afdd8","artifact_type":"open_question","title":"Cell-type specificity**: How does STMN1 function differ across neuron types?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.847127+00:00","updated_at":"2026-04-26T03:29:48.847127+00:00"},{"id":"open_question-5fa3e03e-7bf2-4a0f-b370-cba6dd4c1c8b","artifact_type":"open_question","title":"What is the role of SORCS2 in tau pathology propagation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.795169+00:00","updated_at":"2026-04-26T03:29:48.795169+00:00"},{"id":"open_question-f6f9769f-02f5-4429-9692-5d1b59de40ac","artifact_type":"open_question","title":"How do SORCS2 rare variants contribute to disease pathogenesis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.740294+00:00","updated_at":"2026-04-26T03:29:48.740294+00:00"},{"id":"open_question-9213b2ac-68f1-4c60-b706-b6302866c4fc","artifact_type":"open_question","title":"How does PEX16 coordinate peroxisome assembly?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:44.094817+00:00","updated_at":"2026-04-26T03:29:44.094817+00:00"},{"id":"open_question-783c0ff6-2f94-48e6-8df1-21d5b1c9715b","artifact_type":"open_question","title":"What is the relationship between SORCS2 and other AD risk genes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.686801+00:00","updated_at":"2026-04-26T03:29:48.686801+00:00"},{"id":"open_question-928ade00-9522-4143-877e-31165e1dd1d6","artifact_type":"open_question","title":"Therapeutic windows**: What is the optimal timing for intervention?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.397624+00:00","updated_at":"2026-04-26T03:29:48.397624+00:00"},{"id":"open_question-be0bc2db-f340-4c4f-b884-cce30f1f3dda","artifact_type":"open_question","title":"What determines the balance between proteasome and autophagy?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.569356+00:00","updated_at":"2026-04-26T03:29:43.569356+00:00"},{"id":"open_question-9ddedacc-cd0d-4934-8730-77594b6821f2","artifact_type":"open_question","title":"Paranodal assembly**: What are the precise molecular events in junction formation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.279199+00:00","updated_at":"2026-04-26T03:29:48.279199+00:00"},{"id":"open_question-ebbece52-04e2-4b92-b46e-6b0d3bf399b6","artifact_type":"open_question","title":"Can proteasome enhancement slow disease progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.507337+00:00","updated_at":"2026-04-26T03:29:43.507337+00:00"},{"id":"open_question-ddeb06e8-5f71-4552-afdb-e94c33ba672e","artifact_type":"open_question","title":"How does immunoproteasome activity change with normal aging?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.446543+00:00","updated_at":"2026-04-26T03:29:43.446543+00:00"},{"id":"open_question-66a587c2-e8e5-450e-9952-12c6d85c9fc4","artifact_type":"open_question","title":"Why do certain neuronal populations show vulnerability to proteasome dysfunction?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:43.377299+00:00","updated_at":"2026-04-26T03:29:43.377299+00:00"},{"id":"open_question-9f4f67de-a0c7-4a42-bf5e-ac42441ac3c3","artifact_type":"open_question","title":"Therapeutic targeting**: Can lipid droplet pathways be safely modulated?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:48.002679+00:00","updated_at":"2026-04-26T03:29:48.002679+00:00"},{"id":"open_question-df76a5ec-b782-458f-9ae4-8c4c92a52c5a","artifact_type":"open_question","title":"Disease mechanisms**: How do lipid droplets contribute to neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.942787+00:00","updated_at":"2026-04-26T03:29:47.942787+00:00"},{"id":"open_question-acc67681-e34c-4654-9045-fd690b29c906","artifact_type":"open_question","title":"Neuronal function**: What is the exact function of PLIN4 in neurons?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.884354+00:00","updated_at":"2026-04-26T03:29:47.884354+00:00"},{"id":"open_question-9d9744b9-8dc5-4cb7-bbeb-016a13aced89","artifact_type":"open_question","title":"Can inhibitory deficits be therapeutically restored?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.400725+00:00","updated_at":"2026-04-26T03:29:47.400725+00:00"},{"id":"open_question-7d89cf53-6b67-414c-86c0-f10bd1a04fe8","artifact_type":"open_question","title":"What determines seizure susceptibility?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:47.338969+00:00","updated_at":"2026-04-26T03:29:47.338969+00:00"},{"id":"open_question-5d791249-5720-40be-8cda-d0a4a2df95e7","artifact_type":"open_question","title":"How does ZIP11 contribute to zinc dysregulation in neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:38.918309+00:00","updated_at":"2026-04-26T03:29:38.918309+00:00"},{"id":"open_question-f257db0e-4e0d-4ac9-9094-eda9a1d40b07","artifact_type":"open_question","title":"What is the precise physiological role of ZIP11 in the brain?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:38.861833+00:00","updated_at":"2026-04-26T03:29:38.861833+00:00"},{"id":"open_question-d404f502-9c2b-4e0a-bd69-582c4f00f31b","artifact_type":"open_question","title":"How do specific mutations affect channel function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:46.773409+00:00","updated_at":"2026-04-26T03:29:46.773409+00:00"},{"id":"open_question-61266d52-bdf1-4470-a4cb-725ab6a88f76","artifact_type":"open_question","title":"Combination therapy**: How does calcium modulation combine with other approaches?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:46.651162+00:00","updated_at":"2026-04-26T03:29:46.651162+00:00"},{"id":"open_question-eb9c8e39-a84e-4596-9ace-7d19f2716f50","artifact_type":"open_question","title":"Biomarker potential**: Is CALM4 useful as a disease biomarker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:46.594173+00:00","updated_at":"2026-04-26T03:29:46.594173+00:00"},{"id":"open_question-genes-axl-e5d01c37","artifact_type":"open_question","title":"Cell-Type Specific Function:","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-ptch2-3b82e104","artifact_type":"open_question","title":"Combination therapy","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-adcy7-09a892ec","artifact_type":"open_question","title":"Brain-penetrant activators","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-tead1-86748f9a","artifact_type":"open_question","title":"Temporal dynamics","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-chmp4b-c5dcf2c4","artifact_type":"open_question","title":"Therapeutic targeting","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-atp2b1-49cfc553","artifact_type":"open_question","title":"Peripheral blood cells","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-snap47-d610d383","artifact_type":"open_question","title":"In Vivo Role","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-snap47-ff0ab7a0","artifact_type":"open_question","title":"Therapeutic Translation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-hmox2-4fdb45eb","artifact_type":"open_question","title":"Precise mechanisms","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-hmox2-ae4fc718","artifact_type":"open_question","title":"Cell type specificity","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-genes-join-de764e13","artifact_type":"open_question","title":"Therapeutic windows","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-94e304c9-c4fc-4cab-b018-007f9f3a3e12","artifact_type":"open_question","title":"Biomarkers:** Could ZnT3 serve as disease biomarker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:45.174414+00:00","updated_at":"2026-04-26T03:29:45.174414+00:00"},{"id":"open_question-af13add3-e794-4175-b844-8d6522178664","artifact_type":"open_question","title":"Can biomarkers predict treatment response?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:42.536469+00:00","updated_at":"2026-04-26T03:28:42.536469+00:00"},{"id":"open_question-f9a82ff0-739f-401b-af74-b6f48f0e9500","artifact_type":"open_question","title":"What determines the balance between dominant-negative and loss-of-function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:32.476727+00:00","updated_at":"2026-04-26T03:27:32.476727+00:00"},{"id":"open_question-e5074fa7-7d52-4ca0-aed9-ee5038de70a5","artifact_type":"open_question","title":"How does DNAJB7 contribute to synaptic protein homeostasis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:37.233705+00:00","updated_at":"2026-04-26T03:26:37.233705+00:00"},{"id":"open_question-3cd7235a-1b3b-4d1d-a3d2-b9f586424628","artifact_type":"open_question","title":"How do genetic variants in ELMO2 contribute to disease risk?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:45.445728+00:00","updated_at":"2026-04-26T03:25:45.445728+00:00"},{"id":"open_question-39d86a48-55a2-43c5-ac6c-6dbd743b3462","artifact_type":"open_question","title":"What is the relationship between PRDX2 oxidation and disease progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:16.711513+00:00","updated_at":"2026-04-26T03:29:16.711513+00:00"},{"id":"open_question-31f3fb79-ef2c-4015-9128-9b669d26d3b6","artifact_type":"open_question","title":"Mechanistic details**: How does CA8 scaffold signaling complexes?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:58.278899+00:00","updated_at":"2026-04-26T03:26:58.278899+00:00"},{"id":"open_question-9a00ffdf-8fad-4cf2-80e0-6fe8d7cf2037","artifact_type":"open_question","title":"Therapeutic targeting**: How can we achieve selective modulation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:54.477878+00:00","updated_at":"2026-04-26T03:28:54.477878+00:00"},{"id":"open_question-10bab331-f26f-4a6f-b7cb-dcab8e2df640","artifact_type":"open_question","title":"Biomarker potential**: Can RAC1 activity serve as a disease biomarker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:54.529592+00:00","updated_at":"2026-04-26T03:28:54.529592+00:00"},{"id":"open_question-0f006ea8-8975-40db-838b-87bdc9eb6de5","artifact_type":"open_question","title":"Which ITGAM signaling states are protective (clearance) versus pathogenic (synapse injury)?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:48.196390+00:00","updated_at":"2026-04-26T03:25:48.196390+00:00"},{"id":"open_question-47cc887f-9ec6-4e81-b6c2-c9842bfe32e8","artifact_type":"open_question","title":"How does ITGAM interact with [APOE](/genes/apoe)-[TREM2](/genes/trem2) programs across disease stages?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:48.416207+00:00","updated_at":"2026-04-26T03:25:48.416207+00:00"},{"id":"open_question-5c18224e-afc2-4312-839f-d6baa3f5beb9","artifact_type":"open_question","title":"What is the precise role of neuronal MLCK in AD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:59.105993+00:00","updated_at":"2026-04-26T03:26:59.105993+00:00"},{"id":"open_question-cc1a088e-b232-48e8-9aba-41e827ba909b","artifact_type":"open_question","title":"Developmental Regulation**: How does GABRA3 expression change across the lifespan?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:21.894575+00:00","updated_at":"2026-04-26T03:28:21.894575+00:00"},{"id":"open_question-genes-mapk9-3fcf5bed","artifact_type":"open_question","title":"Single-cell analysis","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-f43ac972-36e6-468b-bab2-ebd083c3923c","artifact_type":"open_question","title":"Biomarker potential**: Could E2F7 serve as a disease biomarker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:22.182205+00:00","updated_at":"2026-04-26T03:28:22.182205+00:00"},{"id":"open_question-95cec69a-deae-40dd-ab1f-4f25f344f369","artifact_type":"open_question","title":"Delivery methods**: How to achieve adequate brain penetration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:22.403652+00:00","updated_at":"2026-04-26T03:28:22.403652+00:00"},{"id":"open_question-67a412dd-7ac2-4685-9b64-03c638d8b217","artifact_type":"open_question","title":"Can we selectively inhibit pathogenic while preserving protective functions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:00.141070+00:00","updated_at":"2026-04-26T03:27:00.141070+00:00"},{"id":"open_question-genes-mapk9-b21d62bf","artifact_type":"open_question","title":"Gene editing","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-d2f99711-763d-4c3b-bfb2-ae24212a8dda","artifact_type":"open_question","title":"Can it serve as a biomarker for disease progression?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:00.401362+00:00","updated_at":"2026-04-26T03:27:00.401362+00:00"},{"id":"open_question-e7cae8ad-daa2-4c5f-bc18-6f88fb46d1c4","artifact_type":"open_question","title":"How does ASTN1 switch from migration to synaptic roles?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:00.536234+00:00","updated_at":"2026-04-26T03:27:00.536234+00:00"},{"id":"open_question-fab9cc96-bde9-4f25-aca5-5b6df6988d3b","artifact_type":"open_question","title":"How does ASTN1 coordinate migration vs. synaptic function?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:00.929433+00:00","updated_at":"2026-04-26T03:27:00.929433+00:00"},{"id":"open_question-2b5a88db-362d-4315-9767-c6456ea49cf5","artifact_type":"open_question","title":"Which DCTN2 variants reproducibly alter neuronal transport in human systems?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:53.410229+00:00","updated_at":"2026-04-26T03:25:53.410229+00:00"},{"id":"open_question-bffca31c-ad28-47ba-b56f-d19c4efd6b97","artifact_type":"open_question","title":"What is the full spectrum of EPG5 substrates in neurons?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:57.611398+00:00","updated_at":"2026-04-26T03:28:57.611398+00:00"},{"id":"open_question-genes-puma-f61491fa","artifact_type":"open_question","title":"Combination Approaches","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-1335b263-83c0-4b1d-bf72-4ea3456af8e4","artifact_type":"open_question","title":"Biomarker validation**: Is MCCC1 useful for diagnosis?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:02.424481+00:00","updated_at":"2026-04-26T03:27:02.424481+00:00"},{"id":"open_question-genes-rab17-47a64ef0","artifact_type":"open_question","title":"RAB17-specific regulators","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-171ae4d7-54d7-4e9b-98e0-351ef8ed2528","artifact_type":"open_question","title":"How does cGAS-STING interact with other inflammatory pathways?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:58.506482+00:00","updated_at":"2026-04-26T03:28:58.506482+00:00"},{"id":"open_question-91ad23fd-bc4c-430a-bf76-91bbb9c725dd","artifact_type":"open_question","title":"Compensatory mechanisms**: What limits therapeutic efficacy of pathway inhibition?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:03.701941+00:00","updated_at":"2026-04-26T03:27:03.701941+00:00"},{"id":"open_question-6493d1c1-8a04-4151-84f1-d8d85015e1f7","artifact_type":"open_question","title":"Interaction networks**: What are the complete protein-protein interaction networks?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:54.415155+00:00","updated_at":"2026-04-26T03:27:54.415155+00:00"},{"id":"open_question-fb6fc9ce-78f9-4105-9c4b-494f8d73bdf4","artifact_type":"open_question","title":"Therapeutic translation**: Can brain-penetrant Pyk2 inhibitors be developed for clinical use?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:26.054012+00:00","updated_at":"2026-04-26T03:28:26.054012+00:00"},{"id":"open_question-e9944384-7f8f-448c-b58a-09007bdc199e","artifact_type":"open_question","title":"How does MAP6 specifically recognize AIS microtubules?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:00.194750+00:00","updated_at":"2026-04-26T03:29:00.194750+00:00"},{"id":"open_question-254adf65-bea1-4d6c-b2db-cb314a83b2ea","artifact_type":"open_question","title":"What determines the cold-stable vs. cold-labile microtubule populations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:00.286278+00:00","updated_at":"2026-04-26T03:29:00.286278+00:00"},{"id":"open_question-d1b79539-0db7-4818-83ea-d52b88b4f42d","artifact_type":"open_question","title":"What resistance mechanisms will emerge?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:36.431479+00:00","updated_at":"2026-04-26T03:28:36.431479+00:00"},{"id":"open_question-5a6d89c6-8d3a-43b9-ba7d-82297a8a3f6c","artifact_type":"open_question","title":"Disease models**: What are the best cellular and animal models for studying GTF2H2-related neurodegeneration?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:57.504148+00:00","updated_at":"2026-04-26T03:25:57.504148+00:00"},{"id":"open_question-418a5370-d1c9-42e3-b1ca-98bfb014e503","artifact_type":"open_question","title":"Biomarkers**: Could NER capacity or GTF2H2 activity levels serve as biomarkers for neurodegeneration risk?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:57.583127+00:00","updated_at":"2026-04-26T03:25:57.583127+00:00"},{"id":"open_question-7275a6d9-e201-4802-99b6-370683ca24e8","artifact_type":"open_question","title":"How is PEX19 expression regulated in different tissues?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:05.861623+00:00","updated_at":"2026-04-26T03:27:05.861623+00:00"},{"id":"open_question-b842d059-33b8-4b44-a98f-dee2cc275320","artifact_type":"open_question","title":"Can TNR modulation enhance plasticity in disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:37.077231+00:00","updated_at":"2026-04-26T03:28:37.077231+00:00"},{"id":"open_question-92680c86-99db-4430-9138-2e03a8885de5","artifact_type":"open_question","title":"What are the long-term effects of TNR targeting?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:37.132113+00:00","updated_at":"2026-04-26T03:28:37.132113+00:00"},{"id":"open_question-a26b4c88-8912-4601-894e-aca2259694e8","artifact_type":"open_question","title":"What determines TNR's dual roles in repair and inhibition?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:37.350324+00:00","updated_at":"2026-04-26T03:28:37.350324+00:00"},{"id":"open_question-aa540175-4397-4e7a-8bb3-5d8804def7d1","artifact_type":"open_question","title":"How does TNR interact with other ECM molecules?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:37.400983+00:00","updated_at":"2026-04-26T03:28:37.400983+00:00"},{"id":"open_question-e46c7349-fb13-4320-a959-d0dbbedd5b92","artifact_type":"open_question","title":"What is the optimal therapeutic approach?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:58.845333+00:00","updated_at":"2026-04-26T03:25:58.845333+00:00"},{"id":"open_question-cbe59774-65f2-4408-8c0b-618771dedcc1","artifact_type":"open_question","title":"Which specific neuronal cell types mediate the effects?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:59.193041+00:00","updated_at":"2026-04-26T03:25:59.193041+00:00"},{"id":"open_question-ffe2f2c7-b174-4e5e-9e1b-35794897c3ec","artifact_type":"open_question","title":"How do EPHA8 effects interact with other AD/PD genetic risk factors?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:59.311708+00:00","updated_at":"2026-04-26T03:25:59.311708+00:00"},{"id":"open_question-2e6f7d19-68a3-4c83-8677-863231a7b70e","artifact_type":"open_question","title":"What determines whether 14-3-3 theta is protective or pathogenic?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:25:59.469359+00:00","updated_at":"2026-04-26T03:25:59.469359+00:00"},{"id":"open_question-4bcc48bc-ddaa-4b9b-bbea-7f3e3ee0902b","artifact_type":"open_question","title":"Biomarkers**: Are there peripheral markers of TRESK dysfunction?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:27:59.072159+00:00","updated_at":"2026-04-26T03:27:59.072159+00:00"},{"id":"open_question-1c7c5e8a-a95a-4cb0-a81f-9200eb44719a","artifact_type":"open_question","title":"How can therapeutic window be optimized?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:00.136302+00:00","updated_at":"2026-04-26T03:28:00.136302+00:00"},{"id":"open_question-a272062e-74c8-4a04-8f29-00006db79a7e","artifact_type":"open_question","title":"What are the precise molecular mechanisms of SMAD7's neuroprotective effects?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:11.016473+00:00","updated_at":"2026-04-26T03:29:11.016473+00:00"},{"id":"open_question-db641b3d-c399-4ef4-92bc-315117130c38","artifact_type":"open_question","title":"Temporal dynamics**: When is the optimal window for intervention?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:11.285383+00:00","updated_at":"2026-04-26T03:29:11.285383+00:00"},{"id":"open_question-genes-gng3-a7a267c2","artifact_type":"open_question","title":"Biomarker validation","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T00:54:30.013560+00:00","updated_at":"2026-04-26T00:54:30.013560+00:00"},{"id":"open_question-c5122997-e0db-477a-a459-aa84f149dd71","artifact_type":"open_question","title":"Mechanism of unique ROBO3 function:** How does ROBO3 signal differently from ROBO1/ROBO2?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:39.829105+00:00","updated_at":"2026-04-26T03:28:39.829105+00:00"},{"id":"open_question-511f7eee-3ed3-4e6e-8ab6-226273d0d3e5","artifact_type":"open_question","title":"Therapeutic windows:** What is the optimal timing for intervention in HGPPS?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:39.883582+00:00","updated_at":"2026-04-26T03:28:39.883582+00:00"},{"id":"open_question-77bb5cad-112d-40c5-82a5-0de6a5e1d5e5","artifact_type":"open_question","title":"Can EPHA1 activation rescue established pathology in late-stage AD?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:29.714969+00:00","updated_at":"2026-04-26T03:26:29.714969+00:00"},{"id":"open_question-acdc7198-acae-4019-a66b-16d1a9bd9801","artifact_type":"open_question","title":"Biomarker utility**: Is MIEF2 a viable disease marker?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:12.358623+00:00","updated_at":"2026-04-26T03:29:12.358623+00:00"},{"id":"open_question-6a2923d5-b5dc-46db-a5f5-775091b134a2","artifact_type":"open_question","title":"Combination therapy**: Optimal approaches with other targets?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:12.411166+00:00","updated_at":"2026-04-26T03:29:12.411166+00:00"},{"id":"open_question-d64891f6-6070-4eeb-921e-c452629af3f6","artifact_type":"open_question","title":"How does RagA specifically regulate local translation at synapses?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:30.845599+00:00","updated_at":"2026-04-26T03:26:30.845599+00:00"},{"id":"open_question-855a3688-39df-48c9-8f04-d8f757d030d5","artifact_type":"open_question","title":"What determines tissue-specific patterns of RagA activity?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:30.907034+00:00","updated_at":"2026-04-26T03:26:30.907034+00:00"},{"id":"open_question-de544c6c-17be-45c1-8114-90253fdf4ade","artifact_type":"open_question","title":"Can RagA-specific modulators achieve therapeutic benefits without systemic mTORC1 inhibition?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:26:31.025121+00:00","updated_at":"2026-04-26T03:26:31.025121+00:00"},{"id":"open_question-bfd29a84-4566-4ec3-8801-f87795b3a4a1","artifact_type":"open_question","title":"How does NGN2 interact with disease-specific mutations?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:12.787805+00:00","updated_at":"2026-04-26T03:29:12.787805+00:00"},{"id":"open_question-4ec42f43-ca46-4271-9ee2-996deb977fca","artifact_type":"open_question","title":"Can NGN2 modulation treat neurodegenerative disease?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:12.840645+00:00","updated_at":"2026-04-26T03:29:12.840645+00:00"},{"id":"open_question-7f61295a-ffd9-404d-802c-35be2a79d67b","artifact_type":"open_question","title":"Can EPHA7 activation rescue established pathology?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.085984+00:00","updated_at":"2026-04-26T03:28:41.085984+00:00"},{"id":"open_question-090b1a0f-f368-4c08-8fea-05ce4a18f5d6","artifact_type":"open_question","title":"What is the optimal therapeutic approach: agonism vs. modulation?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.148885+00:00","updated_at":"2026-04-26T03:28:41.148885+00:00"},{"id":"open_question-77357a26-d092-4c3a-b5f8-232cd902a01d","artifact_type":"open_question","title":"What is the precise molecular mechanism of EPHA7-mediated neuroprotection?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:41.368662+00:00","updated_at":"2026-04-26T03:28:41.368662+00:00"},{"id":"open_question-7b961fb5-5d62-4c94-882e-25645d4a2e93","artifact_type":"open_question","title":"How does CCR8 signaling differ between tissue compartments?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:13.414779+00:00","updated_at":"2026-04-26T03:29:13.414779+00:00"},{"id":"open_question-92309f48-14a0-49fd-8178-cece4160de31","artifact_type":"open_question","title":"What are the cell-type specific roles of PLIN2?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:42.066888+00:00","updated_at":"2026-04-26T03:28:42.066888+00:00"},{"id":"open_question-c8a18180-9ab6-431c-8b7f-9a9e6574fb61","artifact_type":"open_question","title":"How is Munc13-2 regulated in different brain regions?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:28:42.188769+00:00","updated_at":"2026-04-26T03:28:42.188769+00:00"},{"id":"open_question-7d7dfb52-0d6d-491f-b28e-881b3b35cca0","artifact_type":"open_question","title":"Biomarker validation**: Can STMN1 be clinically useful?","quality_score":0.5,"metadata":{},"created_at":"2026-04-26T03:29:49.026862+00:00","updated_at":"2026-04-26T03:29:49.026862+00:00"}],"total":1511,"limit":100,"offset":0,"returned":100,"sort":"importance_elo","field":"genes"}